HDAC9 and colonic neoplasm: BOU exerted a significant short-term antitumor effect in vivo on the colon cancer mouse model (Figure 3A), which was attributed to alteration of inflammatory proteins and early oxidative stress mechanisms (Table S2) combined with HDAC inhibition.